- CA$857.69m
- CA$1.42bn
- CA$897.57m
- 80
- 51
- 67
- 73
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 585 | 640 | 605 | 744 | 898 |
Cost of Revenue | |||||
Gross Profit | 428 | 470 | 449 | 556 | 651 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 556 | 592 | 549 | 677 | 818 |
Operating Profit | 28.8 | 47.5 | 55.3 | 66.7 | 79.6 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 21.3 | 35.1 | 43.5 | 56.1 | 64.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | 18 | 26.4 | 32.8 | 45.6 | 54 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 18.1 | 26.2 | 32.6 | 45.4 | 53.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 18.1 | 26.2 | 32.6 | 45.4 | 53.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.76 | 1.93 | 1.61 | 3.24 | 4.03 |
Dividends per Share |